| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
SARS-CoV-2 RNA, Influenza A/B, and RSV RNA, Qualitative NAAT : 39816
Test CodeCVFRSV or 39816
Alias/See Also
Novel Coronavirus, nCOV, COVID-19, COVID 19, Flu A/B, Wuhan, Coronavirus
CPT Codes
0241U
Includes
Includes: Influenza A RNA, Influenza B RNA, RSV RNA, SARS CoV2 RNA
Instructions
Cold packs/pouches should be used if placing specimens in a lockbox for courier pick-up. Each COVID-19/Flu AB/RSV specimen transport vial that is submitted should be accompanied by its own separate requisition and transported in its own sealed bag.
Transport Container
Preferred Specimen:
One (1) nasopharyngeal or nasal swab collected in VCM, UTM, Saline, or equivalent media.
Alternate Specimen:
Nasal wash aspirate collected into VCM, UTM, Saline or equivalent media.
Minimum Volume:
1 swab in transport media; 1 swab in transport nasopharyngeal or nasal swab; 0.6 mL nasal wash aspirate in 3 mL viral transport.
One (1) nasopharyngeal or nasal swab collected in VCM, UTM, Saline, or equivalent media.
Alternate Specimen:
Nasal wash aspirate collected into VCM, UTM, Saline or equivalent media.
Minimum Volume:
1 swab in transport media; 1 swab in transport nasopharyngeal or nasal swab; 0.6 mL nasal wash aspirate in 3 mL viral transport.
Transport Temperature
Refrigerated.
Specimen Stability
Room temperature: 24 hours; Refrigerated: 7 days; Frozen: 30 days (-70 degrees Celsius)
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Calcium alginate swabs, Cotton swabs in wooden shaft, Amies liquid or gel transport for bacterial cultures, Tubes with clot activator, Glass tubes, Snap-cap tubes, 3D printed swabs, Media with guanidine isothiocyanate (GITC) due to safety concerns, Specimen at room temperature for >24 hours, Throat and lower respiratory samples, Transport tube with the swab inverted
Methodology
Real Time – Polymerase Chain Reaction (RT-PCR)
Setup Schedule
Sunday - Saturday
Report Available
1 day
Limitations
This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.
Reference Range
Influenza A RNA Not detected
Influenza B RNA Not detected
RSV RNA Not detected
SARS CoV2 RNA Not detected
Influenza B RNA Not detected
RSV RNA Not detected
SARS CoV2 RNA Not detected
Clinical Significance
SARS-CoV-2 RNA, Influenza A/B, and RSV RNA, Qualitative NAAT - SARS-CoV-2 RNA, Influenza A/B, and RSV RNA, Qualitative NAAT is a multitarget molecular test that aids in simultaneous qualitative detection and differentiation of SARS-CoV-2 (COVID-19), influenza A, influenza B, and respiratory syncytial virus (RSV) viral RNA. This test is intended to be performed on respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 or influenza or RSV by their healthcare provider. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2, influenza, and RSV can be similar.
Performing Laboratory
med fusion
